New research suggests that individuals who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who halt conventional diet and exercise programs.
Published data in a major health publication demonstrates that while overweight people often shed about a fifth of their body weight while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals using these drugs should be cognizant of the danger of quick rebound weight gain when the medication is stopped," warns lead investigator Dr. Susan Jebb.
That rate of regain means a reversion to original mass in about 18 months.
Weighing Treatments
The research, which reviewed dozens of studies involving over 9,000 of participants, contrasted the outcomes of these new drugs with older methods.
Researchers point out that people who shed pounds through diet and exercise generally see a slower weight regain—around 100 grams monthly—after stopping.
The Reason for the Quick Rebound
Experts believe the way of the injections accounts for the accelerated rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of the hormone concentrations several times higher than the body's typical production may cause the system to produce less of its endogenous hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this GLP-1 'fix' results in hunger is no longer kept in check, making binge eating far more likely."
A Lifelong Disease?
Health authorities suggest the injections for people with obesity-related health risks, alongside prescribed lifestyle changes.
A number of clinicians contend that, given the likelihood of relapse, the treatment is often ongoing.
This perspective is supported by pharmaceutical companies, who say that the results "highlight the long-term character of excess weight," akin to managing diseases like high blood pressure.
User Testimonies
Individuals who have come off the jabs report a sudden resurgence of appetite.
"I experienced a switch that goes on and you become starving," recalled one woman.
The struggle is compounded if individuals have not established sustainable lifestyle or habit changes during treatment.
Widespread Adoption
Survey data show that a significant number of people in the UK have used weight-loss jabs in the past year, with interest remaining high.
- Adoption is more common among females compared to men.
- The middle-aged age group shows the highest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
Finally, experts stress that while the jabs are effective agents for weight loss, they are not a magic fix and long-term success relies on integrated lifestyle support.
